Dr. Walid Khaled - Group Leader
Tel:+44- 01223 334035/334029
Fax: +44 1223 334100
Cancer biology, Cancer therapeutics, Molecular biology, proteomics, genetic screens, Chip-seq.
My primary research interest lies at the interface between basic developmental biology and cancer development. I am particularly interested in the transcriptional control of cell fate in the mammary epithelium and how we can use these unique transcription factors to specifically target the different subtypes of breast cancer. I utilise both candidate and high throughput approaches for the identification and characterization cell fate regulators with the ultimate aim of developing therapeutic methods for use in the clinic.
Dr. Pentao Liu, Sanger Institute
Dr. Jason Carroll, CRUK CI
Prof. Carlos Caldas, CRUK CI
Dr. John Stingl, CRUK CI
Prof. Christine Watson, Pathology Cambridge